VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+21.92%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
10 Year Return
AUM
$374M
AUM Growth
+$374M
Cap. Flow
+$6.39M
Cap. Flow %
1.71%
Top 10 Hldgs %
86.42%
Holding
21
New
3
Increased
2
Reduced
3
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ECYT
1
DELISTED
Endocyte, Inc. Common Stock
ECYT
$74.8M 19.97% 4,211,302 -88,698 -2% -$1.58M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$53.1M 14.19% 1,415,391
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
$40.6M 10.85% 2,252,460
ASND icon
4
Ascendis Pharma
ASND
$11.8B
$35.7M 9.54% 504,210
TCDA
5
DELISTED
Tricida, Inc. Common Stock
TCDA
$29.4M 7.85% 962,696
BCRX icon
6
BioCryst Pharmaceuticals
BCRX
$1.74B
$24.8M 6.62% 3,249,164 +784,923 +32% +$5.99M
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
$18M 4.8% 362,010
KALV icon
8
KalVista Pharmaceuticals
KALV
$678M
$16.8M 4.48% +759,181 New +$16.8M
KNSA icon
9
Kiniksa Pharmaceuticals
KNSA
$2.48B
$16.3M 4.35% 639,230
DBVT
10
DBV Technologies
DBVT
$264M
$14.1M 3.76% 463,149
RARX
11
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$9.85M 2.63% 544,612
ARGX icon
12
argenx
ARGX
$43.6B
$9.19M 2.45% 121,581 -225,211 -65% -$17M
MNTA
13
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6.91M 1.85% 262,822 -162,178 -38% -$4.27M
SPRO icon
14
Spero Therapeutics
SPRO
$116M
$4.98M 1.33% 474,015
CNST
15
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4.89M 1.31% +726,677 New +$4.89M
KDMN
16
DELISTED
Kadmon Holdings, Inc.
KDMN
$4.71M 1.26% 1,411,428
BLPH
17
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4.48M 1.2% 4,149,378
MRNS
18
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.97M 1.06% 397,236 +51,996 +15% +$520K
MTVA
19
MetaVia Inc. Common Stock
MTVA
$15.3M
$1.06M 0.28% +513,752 New +$1.06M
APLS icon
20
Apellis Pharmaceuticals
APLS
$3.48B
$528K 0.14% 29,710
CCXI
21
DELISTED
ChemoCentryx, Inc.
CCXI
$292K 0.08% 23,064